XTX501, a potential best-in-class bispecific PD-1 / masked IL-2, on track for planned IND submission in mid-2026 and Phase 1 ...
SELECT was a large study focused on obesity and cardiovascular disease in people without type 2 diabetes, but it included ...
Researchers developed a compound that protects the liver after small bowel resection in mice. The drug improved nutrient ...
Male contraceptive research is advancing, with oral, injectable, and topical options entering clinical trials. Both hormonal ...
ACI-7104 Phase 2 data and mid-2026 readout, plus FY25 cash burn and dilution risk—see key catalysts and what to do now.
Q4 2025 Earnings Call March 16, 2026 8:00 AM EDTCompany ParticipantsKristal Li - Investor Relations ManagerYan Li - Chairman, ...
Week Study to Evaluate One-Step Dose Titration to 48 mg and Two-Step Dose Titration to 64 mg in Obese Otherwise Healthy Adults CAMBRIDGE, Mass., March 18, 2026 ...
Positive interim Phase 1/2 INSPIRE DUCHENNE data reported at the 2026 MDA Annual Meeting continued to suggest differentiated ...
Stevens Point Journal on MSN
Meet candidates vying for 4 seats on the Stevens Point School Board
Incumbents Ted Kowalski, Gee Pope, Elizabeth Potter-Nelson and Alex Sommers will face challengers Miguel Campos, Jeff Ebel ...
An American winery closed almost every day of 2025, as Trump tariffs resulted in an almost 80% drop of Canadian consumption ...
Presented positive results from the Phase 2 REGEN-007 study of rilparencel in patients with advanced CKD and diabetes as a late-breaking clinical trial at the American Society of Nephrology (ASN) ...
BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results